// App-Quantinova.ai

: ATG-Ptcy-CSA for Gvhd Prevention in Peripheral Blood Haploidentical Hematopoietic Cell Transplantation for Adults with Hematological Malignancies

Researchers

Presenter

  • Maria Queralt Salas

Principal Investigators

  • Abel Santos Carreira

  • Eshetu G. Atenafu

  • Tommy Alfaro Moya

  • Arjun D. Law

  • Wilson Lam

  • Ivan Pasic

  • Carol Chen

  • Dennis Dong Hwan Kim

  • Fotios V. Michelis

  • Armin Gerbitz

  • Jeffrey H. Lipton

  • Rajat Kumar

  • Jonas Mattsson

  • Auro Viswabandya

Medical Centers

  • Allogeneic Hematopoietic Cell Transplant Program, Princess Margaret Cancer Center, Toronto, Canada

  • Hans Messner Allogeneic Blood and Marrow Transplant Unit, Princess Margaret Cancer Centre, Toronto, Canada

  • Hans Messner Allogenic Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, Canada

  • Hans Messner Allogenic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

  • Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

  • Hematopoietic Cell Transplant Unit, Hospital Clinic de Barcelona, Barcelona, Spain

Locations

  • Canada

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Autoimmune (AI)

Disease

  • Hematological malignancies

  • Graft-versus-host disease

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Cyclosporine eent

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved